ID
16915
Description
Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00216151
Link
https://clinicaltrials.gov/show/NCT00216151
Keywords
Versions (1)
- 8/14/16 8/14/16 -
Uploaded on
August 14, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Multiple Myeloma NCT00216151
Eligibility Multiple Myeloma NCT00216151
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Bisphosphonates
Data type
boolean
Alias
- UMLS CUI [1]
- C0012544
Description
Disorders of the parathyroid or thyroid glands
Data type
boolean
Alias
- UMLS CUI [1]
- C0030517
- UMLS CUI [2]
- C0040128
Description
Breast feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0006147
Description
Prior malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Similar models
Eligibility Multiple Myeloma NCT00216151
- StudyEvent: Eligibility
C0231221 (UMLS CUI [1,2])
C0221204 (UMLS CUI [2])
C0016663 (UMLS CUI [3])
C0029453 (UMLS CUI [4])
C0002726 (UMLS CUI [2])
C0239998 (UMLS CUI [3])
C3854607 (UMLS CUI [1,2])
C0040128 (UMLS CUI [2])